Thus, to test whether TRIP12 inhibition will sensitize other cancer cells to Taxol, we knockdown TRIP12 in ovarian cancer cells and treated those cells with increasing doses of Taxol. The gene discussed is TRIP12; the disease is ovarian carcinoma.